Previous studies found that YB-1 in pancreatic cancer, colorectal cancer, breast cancer, melanoma and sarcoma was dramatically raised27–29; studies had also shown that the expression of YB-1 in HCC was closely related to the acquisition of stem cell characteristics, drug resistance, migration and proliferation, etc.27. Here, YBX1 is linked to breast carcinoma.